Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Glaukos Corp
Today
Create an eToro account to buy GKOS stock on a secure, user-friendly, multi-asset trading platform.
Buy Glaukos Corp
Buy Glaukos Corp
Glaukos Corp GKOS
Buy GKOS
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
174
Based on analysts who covered GKOS

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
Stocks-GKOS-Glaukos Corp

Glaukos Corp GKOS

$97.791.12(1.16%)(1D)
• NYSE • in USD

GKOS Stock Price Chart

‎-31.93‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Glaukos Corp share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Glaukos Corp share price today is $97.79, reflecting a ‎1.16‎% change over the last 24 hours and ‎-13.32‎% over the past week. The current market capitalization of GKOS is 5.53B with an average volume in the last three months of 802406.92. The stock has a P/E ratio of -34.76 and a dividend yield of 0%. With the stock’s beta sitting at 1.21
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$5.53B
Day’s Range
i
Shows the high and low prices of the day.
91.64 - 136.64
52W Range
i
Shows the high and low prices of the last year.
59.11 - 163.43
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
802406.92
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-34.76
Revenue
i
The total income generated by this company’s goods and services last year.
$383.48M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$97.79
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-2.81
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.21
What Is Glaukos Corp?
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company that operates globally. It focuses on developing treatments for corneal disorders, glaucoma, and retinal diseases. Incorporated in 1998, Glaukos has its headquarters in Laguna Hills, California.

Glaukos was a pioneer in the field of micro-invasive glaucoma surgery (MIGS), developed as an alternative to traditional glaucoma treatment. The company's products include the iStent, the iStent inject, and the iStent inject W, all micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through MIGS. To treat corneal disorder and keratoconus, Glaukos also offers bio-activated pharmaceutical therapy. The company's products are marketed through both a direct sales network and through distributors around the world.

Trading on the NYSE, Glaukos is listed under the ticker GKOS. In addition to its existing products, Glaukos also has a pipeline of surgical devices, implantable biosensors, and sustained pharmaceutical therapies in development. Products under development include the iStent Infinite to treat refractory glaucoma, iStent SA to treat mild-to-moderate glaucoma pseudophakic, and iDose TR, which is a targeted injectable implant that delivers therapeutic levels of medication for glaucoma treatment.

Keep up to date with the latest news and GKOS share price updates by adding it to your virtual eToro portfolio.
Buy GKOS

How can I buy Glaukos Corp stocks?

To purchase Glaukos Corp:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Glaukos Corp (GKOS) page and place an order to buy Glaukos Corp.
Buy GKOS
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Glaukos Corp
Invest in Glaukos Corp
Today
Create an eToro account to buy GKOS stock on a secure, user-friendly, multi-asset trading platform.
Buy GKOS

FAQ

The current price of GKOS is $97.79.
The average price target for Glaukos Corp is $97.79. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Glaukos Corp based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Glaukos Corp is $5.53B
Daily Movers
Explore the biggest stocks movers on the market.
Buy GKOS
Scroll to top